The future trajectory of adverse outcome pathways: a commentary

被引:0
|
作者
Fiona Sewell
Nichola Gellatly
Maria Beaumont
Natalie Burden
Richard Currie
Lolke de Haan
Thomas H. Hutchinson
Miriam Jacobs
Catherine Mahony
Ian Malcomber
Jyotigna Mehta
Graham Whale
Ian Kimber
机构
[1] National Centre for the Replacement,School of Geography, Earth and Environmental Sciences
[2] Refinement and Reduction of Animals in Research (NC3Rs),Faculty of Biology, Medicine and Health
[3] GlaxoSmithKline,undefined
[4] Syngenta Ltd.,undefined
[5] Jealott’s Hill International Research Centre,undefined
[6] MedImmune,undefined
[7] University of Plymouth,undefined
[8] Public Health England,undefined
[9] Procter and Gamble Company,undefined
[10] Unilever,undefined
[11] Safety and Environmental Assurance Centre,undefined
[12] Dow AgroSciences,undefined
[13] European Development Centre,undefined
[14] Shell,undefined
[15] Health,undefined
[16] Shell Centre,undefined
[17] University of Manchester,undefined
来源
Archives of Toxicology | 2018年 / 92卷
关键词
Adverse outcome pathways (AOPs); Hazard identification; Safety assessment; Risk assessment;
D O I
暂无
中图分类号
学科分类号
摘要
The advent of adverse outcome pathways (AOPs) has provided a new lexicon for description of mechanistic toxicology, and a renewed enthusiasm for exploring modes of action resulting in adverse health and environmental effects. In addition, AOPs have been used successfully as a framework for the design and development of non-animal approaches to toxicity testing. Although the value of AOPs is widely recognised, there remain challenges and opportunities associated with their use in practise. The purpose of this article is to consider specifically how the future trajectory of AOPs may provide a basis for addressing some of those challenges and opportunities.
引用
收藏
页码:1657 / 1661
页数:4
相关论文
共 50 条
  • [1] The future trajectory of adverse outcome pathways: a commentary
    Sewell, Fiona
    Gellatly, Nichola
    Beaumont, Maria
    Burden, Natalie
    Currie, Richard
    de Haan, Lolke
    Hutchinson, Thomas H.
    Jacobs, Miriam
    Mahony, Catherine
    Malcomber, Ian
    Mehta, Jyotigna
    Whale, Graham
    Kimber, Ian
    ARCHIVES OF TOXICOLOGY, 2018, 92 (04) : 1657 - 1661
  • [2] Adverse Outcome Pathways are the future for regulatory toxicology
    Wallace, Heather
    Hines, Ron
    TOXICOLOGY LETTERS, 2018, 295 : S12 - S13
  • [3] Adverse outcome pathways: A mechanistic approach for future risk assessments
    Surapureddi, Sailesh
    Irwin, William
    Chang, Daniel
    Scarano, Louis
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [4] Adverse outcome pathways
    Bolt, Hermann M.
    ARCHIVES OF TOXICOLOGY, 2017, 91 (12) : 4023 - 4024
  • [5] Adverse outcome pathways
    Hermann M. Bolt
    Archives of Toxicology, 2017, 91 : 4023 - 4024
  • [6] Adverse outcome pathways and beyond
    Vinken, M.
    TOXICOLOGY LETTERS, 2019, 314 : S30 - S30
  • [7] Stress response pathways, toxicity pathways and adverse outcome pathways
    Paul Jennings
    Archives of Toxicology, 2013, 87 : 13 - 14
  • [8] Stress response pathways, toxicity pathways and adverse outcome pathways
    Jennings, Paul
    ARCHIVES OF TOXICOLOGY, 2013, 87 (01) : 13 - 14
  • [9] Advancing the quantitative understanding of adverse outcome pathways: current status, methodologies, and future directions
    Jeong, Jaeseong
    Gasparyan, Manvel
    Choi, Jinhee
    ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY, 2025, 44 (03) : 614 - 623
  • [10] Adverse outcome pathways: hype or hope?
    Mathieu Vinken
    Maurice Whelan
    Vera Rogiers
    Archives of Toxicology, 2014, 88 : 1 - 2